Kupffer cell-dependent signaling in thyroid hormone calorigenesis: Possible applications for liver preconditioning

Current Signal Transduction Therapy

Volumn 4, Issue 2, 2009, Pages 144-151

  Fernández, Virginia ^a   Videla, Luis A ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Calorigenesis; Kupffer cell; Liver; Oxidative stress; Pre conditioning; Redox upregulation of gene expression; Thyroid hormone

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GADOLINIUM CHLORIDE; HAPTOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE; LIOTHYRONINE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT PROTEIN; STAT3 PROTEIN; THYROID HORMONE; THYROXINE;

CELL FUNCTION; CELL PROLIFERATION; DOSE RESPONSE; DRUG ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HORMONE ACTION; HUMAN; KUPFFER CELL; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; LIVER SURGERY; LIVER TRANSPLANTATION; LOW DRUG DOSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; REVIEW; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; THERMOGENESIS; UPREGULATION;

EID: 70350416961     PISSN: 15743624     EISSN: None     Source Type: Journal    
DOI: 10.2174/157436209788167529     Document Type: Review

References (97)

1. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 2006; 43: S31-S44.
2. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-G26.
3. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125: 1480-91.
4. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-36.
5. Banga NR, Homer-Vanniasinkam S, Graham A, Al-Mukhtar A, White SA, Prasad KR. Ischaemic preconditioning in transplantation and major resection of the liver. Brit J Surg 2005; 92: 528-38.
6. Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Ann Rev Pharmacol Toxicol 1997; 37: 327-38.
7. Vrba J, Modriansky M. Oxidative burst of Kupffer cells: target for liver injury treatment. Biomed Papers 2002; 146: 15-20.
8. Lemasters JJ, Thurman RG. The many facets of reperfusion injury. Gastroenterology 1995; 108: 1317-20.
9. Casillas-Ramirez A, Mosbah IB, Ramalho F, Rosello-Catafau J, Peralta C. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 2006; 79: 1881-94.
10. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-62.
11. Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection performed with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-52.
12. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991; 91: 31S-8S.
13. Martindale JL, Holbrook NJ. Cellular responses to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002; 192: 1-15.
14. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
15. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signaling. Curr Med Chem 2004; 11: 1163-82.
16. Fernández V, Tapia G, Varela P, Romanque P, Cartier-Ugarte D, Videla LA. Thyroid hormone-induced oxidative stress in rodents and humans: a comparative view and relation to redox regulation of gene expression. Comp Biochem Physiol Part C 2006; 142: 231-9.
17. Videla LA, Fernández V, Tapia G, Varela P. Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression. Front Biosci 2007; 12: 1220-8.
18. Tsukamoto H. Redox regulation of cytokine expression in Kupffer cells. Antiox Redox Signal 2002; 4: 741-8.
19. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells host defense and liver disease. Liver Int 2006; 26: 1175-86.
20. Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 2006; 12: 7413-20.
21. Bouwens L, Baekeland M, De Zanger R, Wisse E. Quantitation, tissue distribution, and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 1986; 6: 718- 22.
22. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002; 283: G256-G65.
23. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006; 117: 979-87.
24. Gloire G, Legrand-Poels S, Piette J. NF-..B activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006; 72: 1493-505.
25. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of NF-..B activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 2005; 7: 395-403.
26. Tran-Thi TA, Decker K, Baeuerle PA. Differential activation of transcription factors NF-κB and AP-1 in rat liver macrophages. Hepatology 1995; 22: 613-9.
27. Neuschwander-Tetri BA, Bellezo JM, Britton RS, Bacon BR, Fox ES. Thiol regulation of endotoxin-induced release of tumor necrosis factor α from isolated rat Kupffer cells. Biochem J 1996; 320: 1005-10.
28. Essani NA, Fisher MA, Jaeschke H. Inhibition of NF-κB activation by dimethyl sulfoxide correlates with suppression of TNF-α formation, reduced ICAM-1 gene expression and protection against endotoxin induced liver injury. Shock 1997; 7: 90- 6.
29. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002; 397: 342-4.
30. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001; 81: 1097-142.
31. 3 itself?. Endocrinology 2002; 143: 504-10.
32. Bassett JHD, Harvey CB, Williams GR. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 2003; 213: 1-11.
33. Sobol S. Thyroid hormone action on mitochondrial energy transfer. Biochim Biophis Acta 1993; 1144: 1-16.
34. Lanni A, Moreno M, Lombardi A, Goglia F. Thyroid hormone and uncoupling proteins. FEBS Lett 2003; 543: 5-10.
35. Fernandez V, Videla LA. Influence of hyperthyroidism on superoxide radical and hydrogen peroxide production by rat liver submitochondrial particles. Free Radic Res Commun1993; 18: 329-35.
36. 2 production by rat liver mitochondria. Mol Cell Endocrinol 2003; 205: 185-92.
37. Tata JR, Ernster L, Linberg O. Control of basal metabolic rate by thyroid hormones and cellular function. Nature 1962; 193: 1058-60.
38. Ram PA, Waxman DJ. Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. J Biol Chem 1992; 267: 3294-301.
39. Fernández V, Barrientos X, Kipreos K, Valenzuela A, Videla LA. Superoxide radical generation, NADPH oxidase activity, and cytochrome P450 content in an experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology 1985; 117: 496-501.
40. Fernández V, Massa L, Quiñones L, et al. Effects of γ-hexachlorocyclohexane and L-3,3′,5-triidothyronine on rat liver cytochrome P4502E1-dependent activity and content in relation to microsomal superoxide radical generation. Biol Res 2003; 36: 719-25.
41. Huh K, Kwon TH, Kim JS, Park JM. Role of the hepatic xanthine oxidase in thyroid dysfunction: effect of thyroid hormones in oxidative stress in rat liver. Arch Pharm Res 1998; 21: 236-40.
42. Fernández V, Cornejo P, Tapia G, Videla LA. Influence of hyperthyroidism on the activity of nitric oxide synthase in the rat. Nitric Oxide 1997; 1: 463-8.
43. Just WW, Hartl FU. Rat liver peroxisomes. II. Stimulation of peroxisomal fatty acid β-oxidation by thyroid hormones. Hoppe-Seylers Z Physiol Chem 1983; 354: 1541-7.
44. Asayama K, Dobashi K, Hayashibe H, Megata Y, Kato K. Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology 1987; 121: 2112-8.
45. Fernández V, LLesuy S, Solari L, Kipreos K, Videla LA, Boberis A. Chemiluminescence and respiratory responses related to thyroid hormone-induced liver oxidative stress. Free Radic Res Commun 1988; 5: 77-84.
46. Fernández V, Simizu K, Barros SBM, et al. Effects of hyperthyroidism on rat liver glutathione metabolism: related enzymes, activities, efflux, and turnover. Endocrinology 1991; 129: 85-91.
47. Sir T, Wolff C, Soto JR, Perez G, Armas-Merino R. Relationship between hepatic levels of glutathione and sulphobromophthalein retention in hyperthyroidism. Clin Sci 1987; 73: 235-7.
48. Simon-Giavarotti KA, Rodrigues L, Rodrigues T, Junqueira VBC, Videla LA. Liver microsomal parameters related to oxidative stress and antioxidant systems in hyperthyroid rats subjected to acute lindane treatment. Free Radic Res 1998; 29: 35-42.
49. Fernández V, Videla LA. Effect of hyperthyroidism on the biliary release of thiobarbituric acid reactants in the rat. Toxicol Lett 1996; 84: 149-53.
50. Venditti P, Balestrieri M, Di Meo S, De Leo T. Effect of thyroid state on lipid peroxidation, antioxidant defenses, and susceptibility to oxidative stress in rat tissues. J Endocrinol 1997; 155: 151-7.
51. Das K, Chainy GB. Modulation of rat liver mitochondrial defence system by thyroid hormone. Biochim Biophys Acta 2001; 1537: 1-13.
52. Tapia G, Cornejo P, Fernández V, Videla LA. Protein oxidation in thyroid hormone-induced liver oxidative stress: relation to lipid peroxidation. Toxicol Lett 1999; 106: 209-14.
53. Andican G, Gelisgen R, Civelek S, et al. Oxidative damage to nuclear DNA in hyperthyroid rat liver: inability of vitamin C to prevent the damage. J Toxicol Environ Health A 2004; 67: 413-20.
54. Landriscina C, Petragallo V, Morini P, Marcotrigiano GO. Lipid peroxidation in rat liver microsomes: I. Stimulation of the NADPH-cytochrome P450 reductase-dependent process in hyperthyroid state. Biochem Int 1988; 17: 385-93.
55. Fernández V, Videla LA. Effect of hyperthyroidism on the biliary release of thiobarbituric acid reactants in the rat. Toxicol Lett 1996; 84: 149-53.
56. Tapia G, Pepper I, Smok G, Videla LA. Kupffer cell function in thyroid hormone-induced liver oxidative stress. Free Radic Res 1997; 26: 267-79.
57. Gomes LF, Lorente S, Simon-Giavarotti KA, Areco KN, Araujo-Peres C, Videla LA. Tri-iodothyronine differentially induces Kupffer cell ED1/ED2 subpopulations. Mol Aspects Med 2004; 25: 183-90.
58. Cowper KB, Currin RT, Dawson TL, Lindert KA, Lemasters JJ, Thurman RG. A new method to monitor Kupffer-cell function continuously in the perfused rat liver. Biochem J 1990; 266: 141-7.
59. 2, and HOCl. Arch Biochem Biophys 1993; 304: 189-96.
60. Hardonk MJ, Dijkhuis FWJ, Hultaert CE, Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride elimination and repopulation. J Leukoc Biol 1992; 52: 296-302.
61. Sellitti DF, Oliver C, Latham KR. Antibodies to nuclear thyroid hormone-binding proteins. Antibody characterization and immunofluorescent localization. Exp Cell Res 1985; 158: 223-36.
62. Fernández V, Videla LA, Tapia G, Israel Y. Increases in tumor necrosis factor-α in response to thyroid hormone-induced liver oxidative stress in the rat. Free Radic Res 2002; 36: 719-25.
63. Tapia G, Fernández V, Varela P, Cornejo P, Guerrero J, Videla LA. Thyroid hormone-induced oxidative stress triggers nuclear factor-κB activation and cytokine gene expression in rat liver. Free Radic Biol Med 2003; 35: 257-65.
64. Tapia G, Fernández V, Pino C, Ardiles R, Videla LA. The acute-phase response of the liver in relation to thyroid hormone-induced redox signaling. Free Radic Biol Med 2006; 40: 1628-35.
65. Romanque P, Tapia G, Videla LA. Kupffer cell stimulation in the isolated perfused rat liver triggers nuclear factor-κB DNA binding activity. Redox Report 2003; 8: 341-6.
66. Tsukamoto H, Lin M. In: Wisse E, Knook DL, Balabaud C, Eds. Cells of the Hepatic Sinusoid. Leiden. The Netherlands, Kupffer Cell Foundation. 1997; 244-50.
67. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cathectin) is an endogenous pyrogen and induced production of interleukin-1. J Exp Med 1986; 163: 1433-50.
68. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19: 2548-56.
69. Heinrich PC, Behrmann I, Hann S, Hermanns HM, Müller-Newen G, Schaper F. Principles in interleukin (IL)-6-type signalling and its regulation. Biochem J 2003; 374: 1-20.
70. MacEwan DJ. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 2002; 14: 477-92.
71. Fernández V, Tapia G, Varela P, Videla LA. Redox regulation of thyroid hormone-induced Kupffer cell-dependent IκB-α phosphorylation in relation to inducible nitric oxide synthase expression. Free Radic Res 2005; 39: 411-8.
72. Fernández V, Tapia G, Varela P, et al. Redox up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of κB-α phosphorylation and nuclear factor-κB activation. J Endocrinol 2005; 186: 539-47.
73. Ernst M, Jenkins BJ. Acquiring signaling specificity from the cytokine receptor gp130. Trends Genet 2004; 20: 23-32.
74. Samols D, Agrawal A, Krushner I. In: Oppenheim JJ, Feldman M, Eds. Cytokine Reference On-line. London: Academic Press; 2003. 75 Griffin EE, Miller LL. Effects of hypothyroidism, hyperthyroidism, and thyroxine on net synthesis of plasma proteins by the isolated perfused rat liver. J Biol Chem 1973; 248: 4716-23.
75. Lin KH, Lee HY, Shih CH, et al. Plasma protein regulation by thyroid hormone. J Endocrinol 2003; 179: 367-77.
76. Fitch CA, Song Y, Leverson CW. Developmental regulation of hepatic ceruloplasmin mRNA and serum activity by exogenous thyroxine and dexamethasone. Proc Soc Exp Biol Med 1999; 221: 27-31.
77. Leedman PJ, Stein AR, Chin WW, Rogers JT. Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J Biol Chem 1996; 271: 12017-23.
78. Fernández V, Reyes S, Bravo S, et al. Involvement of Kupffer cell-dependent signaling in T3-induced hepatocyte proliferation in vivo. Biol Chem 2007; 388: 831-7.
79. Venditti P, Di Meo S. Thyroid hormone-induced oxidative stress. Cell Mol Life Sci 2006; 63: 414-34.
80. Goglia F, Skulachev VP. A function for novel uncoupling proteins: antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to outer membrane leaflet. FASEB J 2003; 17: 1585-91.
81. Grant N. The role of triiodothyronine-induced substrate cycles in the response to overnutrition: thyroid hormone as an antioxidant. Med Hypotheses 2007; 68: 641-8.
82. Fernández V, Castillo I, Tapia G, et al. Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Hepatology 2007; 45: 170-7.
83. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob W, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J Biol Chem 1992; 267: 5317-23.
84. Jaeschke H, Lemasters JJ. Apoptotic versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-57.
85. Heyninck K, Wullaert A, Beyyaert R. Nuclear factor-kappa B plays a central role in tumor necrosis factor-mediated liver disease. Biochem Pharmacol 2003; 66: 1409-15.
86. Takahashi Y, Ganster RW, Gambotto A, et al. Role of NF-κB in liver cold ischemia-reperfusion injury. Am J Physiol Gastroint Liver Physiol 2002; 283: G1175-G1184.
87. Francavilla A, Carr BI, Azzarone A, et al. Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 1994; 20: 1237-41.
88. Columbano A, Shinozuko H. Liver regeneration versus direct hyperplasia. FASEB J 1996; 10: 1118-28.
89. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45-S53.
90. 31P-NMR study. Circ Res 1990; 66: 735-46.
91. Pantos CI, Malliopoulou VA, Mourouzis IS, et al. Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid 2002; 12: 325-9.
92. Pantos CI, Malliopoulou VA, Mourouzis IS, et al. Long-term thyroxine administration increases heat stress protein-70 mRNA expression and attenuates p38 MAP kinase activity in response to ischaemia. J Endocrinol 2001; 170: 207-15.
93. 2 by thyroid hormone and fructose-1,6-bisphosphate. Biochemistry 1991; 30: 7105-11.
94. Davis PJ, Tillmann HC, Davis FB, Wehling M. Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones. J Endocrinol Invest 2002; 25: 377-88.
95. Mezosi E, Szabo J, Nagy EV, et al. Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes. J Endocrinol 2005; 185: 121-9.
96. Fernández V, Tapia G, Varela P, et al. Causal role of oxidative stress in liver preconditioning by thyroid hormone in rats. Free Radic Biol Med 2008; 44: 1724-31.
97. Brent GA, Larsen PR. In: Braverman LE, Utiger RD, Eds. Werner and Ingbar's The Thyroid. Philadelphia, Lippincott-Raven Publishers. 1996; 883-7.